Ligand validation:6RY2

MAN: alpha-D-mannopyranose

MAN is a Ligand Of Interest in 6RY2 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6RY2_MAN_A_706	96%	49%	0.063	0.972	0.83	1.13	-	1	0	0	100%	1
6RY2_MAN_A_705	16%	45%	0.142	0.724	0.53	1.55	-	2	0	0	92%	0.75
6RY1_MAN_A_705	68%	43%	0.101	0.912	1	1.2	1	1	0	0	100%	0.8
5O2X_MAN_A_311	100%	66%	0.023	0.995	0.37	0.94	-	1	0	0	100%	1
7C3C_MAN_A_401	100%	65%	0.039	0.988	0.72	0.62	-	-	0	0	100%	1
5JUG_MAN_A_202	100%	57%	0.038	0.985	0.44	1.2	-	1	0	0	100%	0.4
1GAI_MAN_A_480	100%	75%	0.043	0.986	0.45	0.53	-	-	0	0	100%	1
5AGD_MAN_B_500	100%	38%	0.041	0.982	0.53	1.88	-	4	0	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.